
Vitestro launches new website and first public video of Aletta® Autonomous Robotic Phlebotomy Device™
Vitestro, a pioneer in medical robotics advancing automated diagnostic blood collection, today announced the launch of its new corporate website and the release of its first publicly available video. The video demonstrates the Aletta® Autonomous Robotic Phlebotomy Device™ (ARPD™) performing a diagnostic blood draw. Together, these milestones represent an important step in Vitestro’s evolution toward broader education, clearer communication, and deeper engagement across the healthcare ecosystem. This reflects the company’s continued effort to establish autonomous robotic phlebotomy as a new standard for safe, reliable, and efficient diagnostic blood collection.
https://vitestro.com/news/vitestro-launches-new-website-and-first-public-video-of-aletta-autonomous-robotic-phlebotomy-device/Ander nieuws

Vitestro haalt €60 miljoen op in Series B financieringsronde voor doorontwikkeling autonome bloedafname en commerciële opschaling
InterVest, Labcorp Venture Fund, Mayo Clinic, MGFO, PGGM, Puma Venture Capital, ROM Utrecht, en Sutter Health investeren samen met bestaande investeerders Invest-NL, European Innovation Council Fund (EIC Fund), NYBC Ventures, en Sonder Capital.
Vitestro Achieves CE Marking for Autonomous Blood Drawing Device
Vitestro is proud to announce that its blood drawing device has received CE marking, acknowledging that the device meets the requirements of the European Medical Device Regulation (MDR) and is now available for commercial use